Nikko Asset Management Americas, Inc. Veracyte, Inc. Transaction History

Nikko Asset Management Americas, Inc.

$7.42 Billion
Q1 2025

A detailed history of Nikko Asset Management Americas, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,261,879 shares of VCYT stock, worth $63 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

2,261,879

Previous 2,493,377 9.28%

Holding current value

$63 Million

Previous $98.7 Million 32.08%

% of portfolio

0.9%

Previous 1.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$29.65 - $46.14 $6.86 Million - $10.7 Million	-231,498 Reduced 9.28%	2,261,879 $67.1 Million
Q4 2024 Feb 10, 2025	SELL	$31.92 - $44.4 $8.08 Million - $11.2 Million	-253,025 Reduced 9.21%	2,493,377 $98.7 Million
Q3 2024 Nov 07, 2024	SELL	$21.0 - $35.25 $9.14 Million - $15.3 Million	-435,190 Reduced 13.68%	2,746,402 $93.5 Million
Q2 2024 Aug 09, 2024	SELL	$18.86 - $23.55 $3.13 Million - $3.91 Million	-165,844 Reduced 4.95%	3,181,592 $68.9 Million
Q1 2024 May 02, 2024	BUY	$21.0 - $29.1 $5.1 Million - $7.06 Million	242,760 Added 7.82%	3,347,436 $74.2 Million
Q4 2023 Feb 08, 2024	SELL	$19.72 - $28.68 $1.36 Million - $1.98 Million	-68,900 Reduced 2.17%	3,104,676 $85.4 Million
Q3 2023 Nov 09, 2023	SELL	$22.33 - $29.92 $1.68 Million - $2.26 Million	-75,437 Reduced 2.32%	3,173,576 $70.9 Million
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $935,486 - $1.2 Million	-44,632 Reduced 1.36%	3,249,013 $82.8 Million
Q1 2023 May 03, 2023	BUY	$20.58 - $27.89 $4.72 Million - $6.39 Million	229,200 Added 7.48%	3,293,645 $73.4 Million
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $926,668 - $1.81 Million	60,527 Added 2.01%	3,064,445 $72.7 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $1.37 Million - $2.3 Million	82,440 Added 2.82%	3,003,918 $45.1 Million
Q2 2022 Aug 04, 2022	SELL	$15.45 - $29.52 $1.45 Million - $2.76 Million	-93,563 Reduced 3.1%	2,921,478 $56.7 Million
Q1 2022 May 06, 2022	SELL	$21.94 - $42.51 $2.33 Million - $4.51 Million	-106,062 Reduced 3.4%	3,015,041 $74.8 Million
Q4 2021 Feb 08, 2022	BUY	$36.09 - $53.79 $5.94 Million - $8.86 Million	164,724 Added 5.57%	3,121,103 $113 Million
Q3 2021 Nov 09, 2021	SELL	$35.62 - $52.97 $7.35 Million - $10.9 Million	-206,433 Reduced 6.53%	2,956,379 $118 Million
Q2 2021 Aug 09, 2021	SELL	$32.94 - $56.62 $4.11 Million - $7.06 Million	-124,717 Reduced 3.79%	3,162,812 $126 Million
Q1 2021 May 03, 2021	BUY	$44.47 - $81.38 $688,884 - $1.26 Million	15,491 Added 0.47%	3,287,529 $177 Million
Q4 2020 Feb 11, 2021	BUY	$32.49 - $61.88 $9.15 Million - $17.4 Million	281,501 Added 9.41%	3,272,038 $160 Million
Q3 2020 Nov 02, 2020	SELL	$26.73 - $35.67 $3.95 Million - $5.28 Million	-147,901 Reduced 4.71%	2,990,537 $80.9 Million
Q2 2020 Aug 07, 2020	SELL	$19.49 - $28.11 $2.9 Million - $4.19 Million	-149,029 Reduced 4.53%	3,138,438 $47.7 Million
Q1 2020 Apr 30, 2020	BUY	$16.13 - $30.17 $3.78 Million - $7.07 Million	234,216 Added 7.67%	3,287,467 $79.9 Million
Q4 2019 Feb 06, 2020	BUY	$20.78 - $29.99 $6.01 Million - $8.67 Million	289,015 Added 10.46%	3,053,251 $85.2 Million
Q3 2019 Oct 29, 2019	BUY	$23.87 - $30.93 $14.7 Million - $19.1 Million	615,988 Added 28.67%	2,764,236 $66.3 Million
Q2 2019 Jul 29, 2019	BUY	$22.1 - $28.56 $34 Million - $44 Million	1,539,114 Added 252.67%	2,148,248 $61.2 Million
Q1 2019 Apr 30, 2019	BUY	$12.0 - $25.76 $7.28 Million - $15.6 Million	606,579 Added 23740.86%	609,134 $15.2 Million
Q4 2018 Feb 08, 2019	SELL	$9.15 - $14.85 $430 - $697	-47 Reduced 1.81%	2,555 $32,000
Q3 2018 Oct 15, 2018	BUY	$9.55 - $12.64 $24,849 - $32,889	2,602 New	2,602 $24,000

Others Institutions Holding VCYT

# of Institutions

306

Shares Held

79.1M

Call Options Held

15.5K

Put Options Held

16.7K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.99B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account

Nikko Asset Management Americas, Inc. Veracyte, Inc. Transaction History